KRAS and colorectal carcinoma: Ultimately, we identified NRG1 as the MPRS component with the strongest LLPS potential and a potential link to KRAS mutation, which prompted us to further investigate and validate it as the most critical MLO-related gene (MRG) in CRC for its biomarker properties.